Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31618231 | 1.00 | CA14 (0.37) | CA14 | |
| SCHEMBL24068405 | 0.95 | CA14 (0.36) | CA14 | |
| SCHEMBL25756359 | 0.93 | CA14 (0.37) | CA14 | |
| SCHEMBL31191847 | 0.92 | CA14 (0.33) | CA14 | |
| SCHEMBL23765709 | 0.92 | CA14 (0.35) | CA14 | |
| SCHEMBL24068409 | 0.92 | CA14 (0.33) | CA14 | |
| SCHEMBL24068676 | 0.92 | CA14 (0.33) | CA14 | |
| SCHEMBL25031581 | 0.92 | CA14 (0.35) | CA14 | |
| SCHEMBL24068328 | 0.92 | CA14 (0.33) | CA14 | |
| SCHEMBL23766011 | 0.92 | CA14 (0.33) | CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260083851-A1 | POTENT ASGPR-BINDING HETEROBIFUNCTIONAL COMPOUNDS FOR THE DEGRADATION OF IMMUNOGLOBULINS AND OTHER PROTEINS | AVILAR THERAPEUTICS, INC. (US) | 2026-03-26 | — | — | US | disclosed |
| EP-3736572-B1 | INTRA-DROPLET SURFACE ENGINEERING TO CAPTURE A MOLECULAR TARGET | UNIV STRASBOURG (FR) | 2024-07-24 | — | — | EP | disclosed |
| WO-2024098039-A2 | POTENT ASGPR-BINDING HETEROBIFUNCTIONAL COMPOUNDS FOR THE DEGRADATION OF IMMUNOGLOBULINS AND OTHER PROTEINS | AVILAR THERAPEUTICS, INC. (US) | 2024-05-10 | — | — | WO | disclosed |
| US-20220074930-A1 | INTRA-DROPLET SURFACE ENGINEERING TO CAPTURE A MOLECULAR TARGET | UNIVERSITE DE STRASBOURG (FR) | 2022-03-10 | — | — | US | disclosed |
| US-11181521-B2 | Intra-droplet surface engineering to capture a molecular target | UNIVERSITE DE STRASBOURG (FR) | 2021-11-23 | — | — | US | disclosed |
| US-11181521-B2 | Intra-droplet surface engineering to capture a molecular target | UNIVERSITE DE STRASBOURG (FR) | 2021-11-23 | — | — | US | disclosed |
| EP-3736572-A1 | INTRA-DROPLET SURFACE ENGINEERING TO CAPTURE A MOLECULAR TARGET | Université de Strasbourg (FR) | 2020-11-11 | — | — | EP | disclosed |
| EP-3440463-B1 | INTRA-DROPLET SURFACE ENGINEERING TO CAPTURE A MOLECULAR TARGET | UNIV STRASBOURG (FR) | 2020-07-08 | — | — | EP | disclosed |
| US-20190113509-A1 | INTRA-DROPLET SURFACE ENGINEERING TO CAPTURE A MOLECULAR TARGET | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2019-04-18 | — | — | US | disclosed |
| US-20190113509-A1 | INTRA-DROPLET SURFACE ENGINEERING TO CAPTURE A MOLECULAR TARGET | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2019-04-18 | — | — | US | disclosed |
| EP-3440463-A1 | INTRA-DROPLET SURFACE ENGINEERING TO CAPTURE A MOLECULAR TARGET | Université de Strasbourg (FR) | 2019-02-13 | — | — | EP | disclosed |
| WO-2017174610-A1 | INTRA-DROPLET SURFACE ENGINEERING TO CAPTURE A MOLECULAR TARGET | UNIVERSITE DE STRASBOURG (FR) | 2017-10-12 | — | — | WO | disclosed |
| WO-2017174610-A1 | INTRA-DROPLET SURFACE ENGINEERING TO CAPTURE A MOLECULAR TARGET | UNIVERSITE DE STRASBOURG (FR) | 2017-10-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260083851-A1 | POTENT ASGPR-BINDING HETEROBIFUNCTIONAL COMPOUNDS FOR THE DEGRADATION OF IMMUNOGLOBULINS AND OTHER PROTEINS | ASGR1, FCGR2A, FCGR3B | CA14 2998/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.